Showing results (1-10 of 361) with videos related to
Sort By:
Pageof 37
Journal of Neuroimmunology|June 16, 2000
The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous systemH P Hartung, B C KieseierDer Nervenarzt|July 21, 1999
[Matrix metalloproteinases. Potential targets for new treatments in inflammatory demyelinating diseases of the nervous system]B C Kieseier, T Seifert, H P HartungDer Nervenarzt|October 11, 2003
[Mitoxanthrone in the therapy of multiple sclerosis]B C Kieseier, R Gold, H-P HartungCurrent Opinion in Neurology|September 20, 2001
Progress in Guillain-Barré syndromeH P Hartung, B C Kieseier, R KieferDer Nervenarzt|February 4, 2010
[Cladribin. Development of an oral formulation for the treatment of multiple sclerosis]H-P Hartung, B C Kieseier, O AktasJournal of Neural Transmission. Supplementum|August 29, 2000
Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous systemB C Kieseier, M K Storch, H P HartungDer Nervenarzt|February 11, 2004
[Jean-Martin Charcot in German neurology]H C Lehmann, H-P Hartung, B C KieseierMultiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2007
Leopold Ordenstein: on paralysis agitans and multiple sclerosisH C Lehmann, H-P Hartung, B C KieseierDer Nervenarzt|March 20, 2009
[Possibilities and risks of the monoclonal antibody alemtuzumab as a new treatment option for multiple sclerosis]C Warnke, B C Kieseier, U Zettl, et al.Der Nervenarzt|April 23, 2003
[Chronic inflammatory demyelinating polyneuropathy]H Köller, B C Kieseier, S Jander, et al.Pageof 37